Michael Matson
Stock Analyst at Needham
(4.28)
# 1,422
Out of 4,692 analysts
1597
Total ratings
50.2%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Reiterated: Buy | $101 → $114 | $90.65 | +25.76% | 98 | Aug 27, 2026 | |
| TFX Teleflex | Rated: Buy | $159 → $170 | $142.05 | +19.68% | 72 | Aug 25, 2026 | |
| HAE Haemonetics | Maintained: Hold | n/a | $103.07 | - | 48 | Aug 18, 2026 | |
| IMDX Insight Molecular Diagnostics | Reiterated: Buy | $9 | $3.92 | +129.59% | 37 | Aug 18, 2026 | |
| PLSE Pulse Biosciences | Initiated Coverage: Buy | $58 | $50.33 | +15.24% | 1 | Aug 17, 2026 | |
| LUCD Lucid Diagnostics | Reiterated: Buy | $3 | $0.9786 | +206.56% | 33 | Aug 13, 2026 | |
| AORT Artivion | Reiterated: Buy | $44 | $26.99 | +63.02% | 61 | Aug 7, 2026 | |
| ICUI ICU Medical | Rated: Buy | $165 → $187 | $172.95 | +8.12% | 14 | Aug 7, 2026 | |
| RMD ResMed | Maintained: Hold | n/a | $240.10 | - | 96 | Aug 7, 2026 | |
| INGN Inogen | Rated: Buy | $12 | $5.37 | +123.46% | 87 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $24.59 | +111.47% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $232.64 | - | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 → $95 | $69.33 | +37.03% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.78 | - | 40 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $100.04 | - | 89 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $93 | $79.81 | +16.53% | 87 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $35 | $23.31 | +50.15% | 52 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $14.96 | - | 42 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $142 → $106 | $84.87 | +24.90% | 29 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $101 | $90.66 | +11.41% | 69 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $418 | $323.80 | +29.09% | 74 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $69 | $43.19 | +59.76% | 36 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $49.85 | - | 83 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 | $48.30 | +18.01% | 128 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $19 | $17.91 | +6.09% | 39 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $48.35 | -6.93% | 103 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $323.10 | - | 24 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.035 | n/a | 2 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 → $82 | $81.37 | n/a | 22 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $19.02 | n/a | 1 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.54 | n/a | 50 | Dec 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.53 | n/a | 10 | Nov 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $9.39 | n/a | 1 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $636 | $376.86 | n/a | 1 | Apr 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $15 → $14 | $10.06 | n/a | 4 | Apr 9, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $9.39 | n/a | 1 | Apr 17, 2009 |
Medtronic
Aug 27, 2026
Reiterated: Buy
Price Target: $101 → $114
Current: $90.65
Upside: +25.76%
Teleflex
Aug 25, 2026
Rated: Buy
Price Target: $159 → $170
Current: $142.05
Upside: +19.68%
Haemonetics
Aug 18, 2026
Maintained: Hold
Price Target: n/a
Current: $103.07
Upside: -
Insight Molecular Diagnostics
Aug 18, 2026
Reiterated: Buy
Price Target: $9
Current: $3.92
Upside: +129.59%
Pulse Biosciences
Aug 17, 2026
Initiated Coverage: Buy
Price Target: $58
Current: $50.33
Upside: +15.24%
Lucid Diagnostics
Aug 13, 2026
Reiterated: Buy
Price Target: $3
Current: $0.9786
Upside: +206.56%
Artivion
Aug 7, 2026
Reiterated: Buy
Price Target: $44
Current: $26.99
Upside: +63.02%
ICU Medical
Aug 7, 2026
Rated: Buy
Price Target: $165 → $187
Current: $172.95
Upside: +8.12%
ResMed
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $240.10
Upside: -
Inogen
Aug 7, 2026
Rated: Buy
Price Target: $12
Current: $5.37
Upside: +123.46%
Aug 6, 2026
Reiterated: Buy
Price Target: $52
Current: $24.59
Upside: +111.47%
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $232.64
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $86 → $95
Current: $69.33
Upside: +37.03%
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $16.78
Upside: -
Aug 5, 2026
Maintained: Hold
Price Target: n/a
Current: $100.04
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: $81 → $93
Current: $79.81
Upside: +16.53%
Aug 5, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $23.31
Upside: +50.15%
Aug 5, 2026
Maintained: Hold
Price Target: n/a
Current: $14.96
Upside: -
Aug 3, 2026
Rated: Buy
Price Target: $142 → $106
Current: $84.87
Upside: +24.90%
Jul 31, 2026
Reiterated: Buy
Price Target: $90 → $101
Current: $90.66
Upside: +11.41%
Jul 31, 2026
Reiterated: Buy
Price Target: $418
Current: $323.80
Upside: +29.09%
Jul 31, 2026
Reiterated: Buy
Price Target: $57 → $69
Current: $43.19
Upside: +59.76%
Jul 30, 2026
Maintained: Hold
Price Target: n/a
Current: $49.85
Upside: -
Jul 29, 2026
Maintained: Buy
Price Target: $57
Current: $48.30
Upside: +18.01%
Jul 29, 2026
Rated: Buy
Price Target: $15 → $19
Current: $17.91
Upside: +6.09%
Jul 24, 2026
Reiterated: Buy
Price Target: $45
Current: $48.35
Upside: -6.93%
Feb 25, 2026
Maintained: Hold
Price Target: n/a
Current: $323.10
Upside: -
Apr 5, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.035
Upside: n/a
May 5, 2021
Maintained: Buy
Price Target: $65 → $82
Current: $81.37
Upside: n/a
Mar 18, 2020
Maintained: Buy
Price Target: $27
Current: $19.02
Upside: n/a
Dec 6, 2018
Rated: Hold
Price Target: n/a
Current: $4.54
Upside: n/a
Nov 11, 2016
Maintained: Buy
Price Target: n/a
Current: $1.53
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $1
Current: $9.39
Upside: n/a
Apr 19, 2013
Maintained: Buy
Price Target: $636
Current: $376.86
Upside: n/a
Apr 9, 2013
Upgraded: Buy
Price Target: $15 → $14
Current: $10.06
Upside: n/a
Apr 17, 2009
Downgraded: Sell
Price Target: n/a
Current: $9.39
Upside: n/a